These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 27543974)

  • 1. Loss of function of SLC25A46 causes lethal congenital pontocerebellar hypoplasia.
    Wan J; Steffen J; Yourshaw M; Mamsa H; Andersen E; Rudnik-Schöneborn S; Pope K; Howell KB; McLean CA; Kornberg AJ; Joseph J; Lockhart PJ; Zerres K; Ryan MM; Nelson SF; Koehler CM; Jen JC
    Brain; 2016 Nov; 139(11):2877-2890. PubMed ID: 27543974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extension of the phenotype of biallelic loss-of-function mutations in SLC25A46 to the severe form of pontocerebellar hypoplasia type I.
    Braunisch MC; Gallwitz H; Abicht A; Diebold I; Holinski-Feder E; Van Maldergem L; Lammens M; Kovács-Nagy R; Alhaddad B; Strom TM; Meitinger T; Senderek J; Rudnik-Schöneborn S; Haack TB
    Clin Genet; 2018 Feb; 93(2):255-265. PubMed ID: 28653766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel insights into SLC25A46-related pathologies in a genetic mouse model.
    Terzenidou ME; Segklia A; Kano T; Papastefanaki F; Karakostas A; Charalambous M; Ioakeimidis F; Papadaki M; Kloukina I; Chrysanthou-Piterou M; Samiotaki M; Panayotou G; Matsas R; Douni E
    PLoS Genet; 2017 Apr; 13(4):e1006656. PubMed ID: 28376086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in SLC25A46, encoding a UGO1-like protein, cause an optic atrophy spectrum disorder.
    Abrams AJ; Hufnagel RB; Rebelo A; Zanna C; Patel N; Gonzalez MA; Campeanu IJ; Griffin LB; Groenewald S; Strickland AV; Tao F; Speziani F; Abreu L; Schüle R; Caporali L; La Morgia C; Maresca A; Liguori R; Lodi R; Ahmed ZM; Sund KL; Wang X; Krueger LA; Peng Y; Prada CE; Prows CA; Schorry EK; Antonellis A; Zimmerman HH; Abdul-Rahman OA; Yang Y; Downes SM; Prince J; Fontanesi F; Barrientos A; Németh AH; Carelli V; Huang T; Zuchner S; Dallman JE
    Nat Genet; 2015 Aug; 47(8):926-32. PubMed ID: 26168012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into the genotype-phenotype correlation and molecular function of SLC25A46.
    Abrams AJ; Fontanesi F; Tan NBL; Buglo E; Campeanu IJ; Rebelo AP; Kornberg AJ; Phelan DG; Stark Z; Zuchner S
    Hum Mutat; 2018 Dec; 39(12):1995-2007. PubMed ID: 30178502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel pathogenic SLC25A46 splice-site mutation causes an optic atrophy spectrum disorder.
    Nguyen M; Boesten I; Hellebrekers DM; Mulder-den Hartog NM; de Coo IF; Smeets HJ; Gerards M
    Clin Genet; 2017 Jan; 91(1):121-125. PubMed ID: 26951855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pontocerebellar hypoplasia with spinal muscular atrophy (PCH1): identification of SLC25A46 mutations in the original Dutch PCH1 family.
    van Dijk T; Rudnik-Schöneborn S; Senderek J; Hajmousa G; Mei H; Dusl M; Aronica E; Barth P; Baas F
    Brain; 2017 Aug; 140(8):e46. PubMed ID: 28637197
    [No Abstract]   [Full Text] [Related]  

  • 8. Bovine and murine models highlight novel roles for SLC25A46 in mitochondrial dynamics and metabolism, with implications for human and animal health.
    Duchesne A; Vaiman A; Castille J; Beauvallet C; Gaignard P; Floriot S; Rodriguez S; Vilotte M; Boulanger L; Passet B; Albaric O; Guillaume F; Boukadiri A; Richard L; Bertaud M; Timsit E; Guatteo R; Jaffrézic F; Calvel P; Helary L; Mahla R; Esquerré D; Péchoux C; Liuu S; Vallat JM; Boichard D; Slama A; Vilotte JL
    PLoS Genet; 2017 Apr; 13(4):e1006597. PubMed ID: 28376083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of SLC25A46 causes neurodegeneration by affecting mitochondrial dynamics and energy production in mice.
    Li Z; Peng Y; Hufnagel RB; Hu YC; Zhao C; Queme LF; Khuchua Z; Driver AM; Dong F; Lu QR; Lindquist DM; Jankowski MP; Stottmann RW; Kao WWY; Huang T
    Hum Mol Genet; 2017 Oct; 26(19):3776-3791. PubMed ID: 28934388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Drosophila model for mitochondrial diseases by targeting of a solute carrier protein SLC25A46.
    Suda K; Ueoka I; Azuma Y; Muraoka Y; Yoshida H; Yamaguchi M
    Brain Res; 2018 Jun; 1689():30-44. PubMed ID: 29604258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of SLC25A46-related pontocerebellar hypoplasia in two siblings with fulminant neonatal course: role of postmortem CT and whole genomic analysis: a case report.
    Yamada M; Suzuki H; Adachi H; Noguchi A; Miya F; Takahashi T; Kosaki K
    BMC Neurol; 2022 Jan; 22(1):20. PubMed ID: 35012485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SLC25A46 mutations in patients with Parkinson's Disease and optic atrophy.
    Bitetto G; Malaguti MC; Ceravolo R; Monfrini E; Straniero L; Morini A; Di Giacopo R; Frosini D; Palermo G; Biella F; Ronchi D; Duga S; Taroni F; Corti S; Comi GP; Bresolin N; Giometto B; Di Fonzo A
    Parkinsonism Relat Disord; 2020 May; 74():1-5. PubMed ID: 32259769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the mitochondrial outer membrane protein SLC25A46 in mitochondrial fission and fusion.
    Schuettpelz J; Janer A; Antonicka H; Shoubridge EA
    Life Sci Alliance; 2023 Jun; 6(6):. PubMed ID: 36977595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pontocerebellar hypoplasia type 2D and optic nerve atrophy further expand the spectrum associated with selenoprotein biosynthesis deficiency.
    Pavlidou E; Salpietro V; Phadke R; Hargreaves IP; Batten L; McElreavy K; Pitt M; Mankad K; Wilson C; Cutrupi MC; Ruggieri M; McCormick D; Saggar A; Kinali M
    Eur J Paediatr Neurol; 2016 May; 20(3):483-8. PubMed ID: 26805434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of Rpd3 suppresses defects in locomotive ability and neuronal morphology induced by the knockdown of Drosophila SLC25A46 via an epigenetic pathway.
    Suda K; Muraoka Y; Ortega-Yáñez A; Yoshida H; Kizu F; Hochin T; Kimura H; Yamaguchi M
    Exp Cell Res; 2019 Dec; 385(2):111673. PubMed ID: 31614134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SLC25A46 mutations underlie progressive myoclonic ataxia with optic atrophy and neuropathy.
    Charlesworth G; Balint B; Mencacci NE; Carr L; Wood NW; Bhatia KP
    Mov Disord; 2016 Aug; 31(8):1249-51. PubMed ID: 27430653
    [No Abstract]   [Full Text] [Related]  

  • 17. Reanalysis of Exome Data Identifies Novel
    Li Q; Madden JA; Lin J; Shi J; Rosen SM; Schmitz-Abe K; Agrawal PB
    J Pers Med; 2021 Dec; 11(12):. PubMed ID: 34945750
    [No Abstract]   [Full Text] [Related]  

  • 18. SLC25A46 is required for mitochondrial lipid homeostasis and cristae maintenance and is responsible for Leigh syndrome.
    Janer A; Prudent J; Paupe V; Fahiminiya S; Majewski J; Sgarioto N; Des Rosiers C; Forest A; Lin ZY; Gingras AC; Mitchell G; McBride HM; Shoubridge EA
    EMBO Mol Med; 2016 Sep; 8(9):1019-38. PubMed ID: 27390132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid degradation of mutant SLC25A46 by the ubiquitin-proteasome system results in MFN1/2-mediated hyperfusion of mitochondria.
    Steffen J; Vashisht AA; Wan J; Jen JC; Claypool SM; Wohlschlegel JA; Koehler CM
    Mol Biol Cell; 2017 Mar; 28(5):600-612. PubMed ID: 28057766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SLC25A46 Mutations Associated with Autosomal Recessive Cerebellar Ataxia in North African Families.
    Hammer MB; Ding J; Mochel F; Eleuch-Fayache G; Charles P; Coutelier M; Gibbs JR; Arepalli SK; Chong SB; Hernandez DG; Majounie E; Clipman S; Bouhlal Y; Nehdi H; Brice A; Hentati F; Stevanin G; Amouri R; Durr A; Singleton AB
    Neurodegener Dis; 2017; 17(4-5):208-212. PubMed ID: 28558379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.